Does VELAGLUCERASE ALFA Cause Inappropriate schedule of product administration? 197 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 197 reports of Inappropriate schedule of product administration have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 11.3% of all adverse event reports for VELAGLUCERASE ALFA.
197
Reports of Inappropriate schedule of product administration with VELAGLUCERASE ALFA
11.3%
of all VELAGLUCERASE ALFA reports
10
Deaths
93
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From VELAGLUCERASE ALFA?
Of the 197 reports, 10 (5.1%) resulted in death, 93 (47.2%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 197 reports have been filed with the FAERS database.
What Other Side Effects Does VELAGLUCERASE ALFA Cause?
Product dose omission issue (188)
Covid-19 (163)
Fatigue (136)
Death (108)
Fall (104)
Pyrexia (101)
Malaise (98)
Weight increased (89)
Headache (88)
Arthralgia (84)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which VELAGLUCERASE ALFA Alternatives Have Lower Inappropriate schedule of product administration Risk?
VELAGLUCERASE ALFA vs VELCADE
VELAGLUCERASE ALFA vs VELETRI
VELAGLUCERASE ALFA vs VELIPARIB
VELAGLUCERASE ALFA vs VEMURAFENIB
VELAGLUCERASE ALFA vs VENETOCLAX